Ikarian Capital, LLC Assembly Biosciences, Inc. Transaction History

Ikarian Capital, LLC

  • $573 Million
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
SELL
$1.35 - $2.29 $306,552 - $520,004
-227,076 Closed
0 $0
Q1 2022

May 13, 2022
BUY
$1.46 - $2.45 $17,833 - $29,926
12,215 Added 5.69%
227,076 $468,000
Q3 2021

Nov 15, 2021
BUY
$3.14 - $3.9 $447,114 - $555,332
142,393 Added 196.49%
214,861 $747,000
Q4 2020

Feb 12, 2021
SELL
$4.87 - $17.29 $413,950 - $1.47 Million
-85,000 Reduced 53.98%
72,468 $439,000
Q4 2019

Jan 31, 2020
BUY
$8.36 - $23.81 $1.32 Million - $3.75 Million
157,468 New
157,468 $3.22 Million

Others Institutions Holding ASMB

# of Institutions
1
Shares Held
16.3K
Call Options Held
0
Put Options Held
0
View Full List

About ASSEMBLY BIOSCIENCES, INC.

ASMB Quotes by TradingView
  • Ticker ASMB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,436,900
  • Market Cap $753M
  • Description
  • Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...
More about ASMB
Track This Portfolio

Track Ikarian Capital, LLC Portfolio

Follow Ikarian Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ikarian Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email